Polyrizon Ltd. (PLRZ) short interest & options flow
NASDAQPLRZ enters the back half of May with a clinical catalyst in hand — and a borrow market that has swung from near-maximum tightness to near-total availability in the space of a fortnight. The catalyst is concrete. Polyrizon signed a clinical trial agreement this week with a U.S. research site specialising in allergy studies, advancing its NASARIX allergy-blocker programme. That…
PLRZ short interest surges 61.6% in one week to 40,786 shares, driven by extreme borrowing costs at 406.8% APR and 77.7% utilization.
- Market cap
- $27M
- Next earnings
- 29 Dec 2026
Key data as of 12 Nov 2026
Latest signals on PLRZ
- Short Interest
PLRZ short interest surges 61.6% in one week to 40,786 shares, driven by extreme borrowing costs at 406.8% APR and 77.7% utilization.
PLRZ news and analysis
RSSNo long-form analysis yet for PLRZ. Pulse alerts and the live data picture are available on ORTEX.
Open PLRZ on ORTEX →Want the live picture for PLRZ?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PLRZ — free to start on ORTEX.
Sign up for free →Open PLRZ on ORTEX